MAOB is linked to increased ROS production, which may promote tumor growth in certain instances, and it has paradoxically been associated with better survival outcomes in breast cancer and has also been investigated as a therapeutic target in colon cancer, glioma, and other forms of cancer [28]. The gene discussed is MAOB; the disease is central nervous system cancer.